Napoli Bern Ripka, LLP Blog

Trouble for Bayer as Lawsuits Draw Near

The suspension of Trasylol, a drug used in heart surgeries sales that has been proven to be fatal, has caused for much talk. Trasylol lawsuits from the families of those affected by the drug’s side-effects will be filed soon, and a Trasylol class-action lawsuit can not be far off. With fatalities over 22,000, Bayer is going to be struggling to find a way out. The drug was speculated to have problems back in 2006, yet it was still approved by the FDA. The reason for this is that Bayer failed to present their research about the relation of kidney failure & Trasylol to the FDA in their September 2006 meeting. The chairman of that FDA advisory panel, Dr. William Hiatt, said that he would have voted for a Trasylol recall back in 2006 if Bayer had not withheld the data from their study

            The high cost of Trasylol has also posed questions due to the fact that it was a lot more expensive at $1,250, than of competitors at $150. This makes us wonder if Bayer was not only producing a defection medication, but also gouging prices from those who were administered Trasylol. What we do know is that Bayer is going to need more than a drug to cure there worries

Napoli Bern Ripka LLP is an experienced firm in the medical negligence field and can provide you with the right information on how to proceed with your case. If you or a loved one have suffered as a result of Trasylol side effects such as kidney failure, heart attack, or stroke you may be entitled to compensation. We are here to help you questions that you may have regarding Trasylol side effects, a possible Trasylol class action lawsuit, or any other type of Trasylol litigation.